Tarsons Products Stock Plummets to All-Time Low Amid Ongoing Decline

Tarsons Products has reached an all-time low as of November 17, 2025, reflecting a significant downturn in its market performance. The small-cap healthcare services company has been on a downward trajectory, with its stock price falling for 11 consecutive days, resulting in an 18.1% decline during this period. Today, Tarsons Products underperformed its sector by 0.51%, closing at a price just 0.11% above its 52-week low of Rs 237.1. Over the past month, the stock has dropped 18.54%, while the broader market, represented by the Sensex, has gained 0.99%. Year-to-date, the stock has seen a decline of 41.39%, contrasting sharply with the Sensex's 8.51% increase. Key financial metrics indicate a challenging environment for Tarsons Products, with a return on capital employed (ROCE) at a low 6.69% and a debt-equity ratio of 0.41 times, the highest in its history. Additionally, institutional investors have reduced their stake by 3.27% in the last quarter, now holding only 5.91% of the company. This consistent underperformance against benchmarks over the past three years highlights the ongoing difficulties faced by Tarsons Products in the current market landscape.